$CXRX,Stock Worth Mentioning: Will Concordia Inter
Post# of 23114
Posted On: 12/19/2016 9:26:28 PM
$CXRX,Stock Worth Mentioning: Will Concordia International Corp Go Down Anytime Soon?
December 19, 2016 Vivian Park
Stock Worth Mentioning: Will Concordia International Corp Go Down Anytime Soon?
The stock of Concordia International Corp (NASDAQ:CXRX) is a huge mover today! The stock increased 7.91% or $0.17 on December 19, hitting $2.32. About 2.55 million shares traded hands or 10.39% up from the average. Concordia International Corp (NASDAQ:CXRX) has declined 92.60% since May 16, 2016 and is downtrending. It has underperformed by 101.87% the S&P500.
The move comes after 7 months positive chart setup for the $109.69 million company. It was reported on Dec, 19 by Barchart.com. We have $2.41 PT which if reached, will make NASDAQ:CXRX worth $4.39M more.
Analysts await Concordia International Corp (NASDAQ:CXRX) to report earnings on March, 22. They expect $-0.03 EPS, down 102.78% or $1.11 from last year’s $1.08 per share. After $-0.33 actual EPS reported by Concordia International Corp for the previous quarter, Wall Street now forecasts -90.91% EPS growth.
Concordia International Corp (NASDAQ:CXRX) Ratings Coverage
Out of 9 analysts covering Concordia Healthcare Corp. (NASDAQ:CXRX), 5 rate it a “Buy”, 0 “Sell”, while 4 “Hold”. This means 56% are positive. Concordia Healthcare Corp. has been the topic of 18 analyst reports since August 11, 2015 according to StockzIntelligence Inc. The firm earned “Sector Outperform” rating on Friday, October 16 by Scotia Capital. The firm has “Sector Outperform” rating by Scotia Capital given on Tuesday, September 29. The company was initiated on Monday, November 30 by IBC. The rating was maintained by S&P Research on Friday, October 16 with “Buy”. RBC Capital Markets reinitiated it with “Outperform” rating and $86 target price in Thursday, October 1 report. On Monday, September 19 the stock rating was upgraded by Scotia Capital to “Sector Perform”. Goldman Sachs initiated Concordia International Corp (NASDAQ:CXRX) on Monday, June 6 with “Neutral” rating. The company was upgraded on Monday, October 19 by Mackie. Laurentian maintained the stock with “Buy” rating in Tuesday, March 29 report. The stock of Concordia International Corp (NASDAQ:CXRX) has “Hold” rating given on Thursday, August 4 by TD Securities.
According to Zacks Investment Research, “Concordia International Corp is a diverse pharmaceutical company which focused on legacy pharmaceutical products and orphan drugs. The company also markets orphan drugs through its Orphan Drug Division, currently consisting of Photofrin(R) for the treatment of certain rare forms of cancer, which is currently undergoing testing for potential new indications. Concordia International Corp, formerly known as Concordia Healthcare Corp, is headquartered in Oakville, Canada.”
More notable recent Concordia International Corp (NASDAQ:CXRX) news were published by: Reuters.com which released: “BRIEF-Concordia International Corp provides business update” on December 19, 2016, also Prnewswire.com with their article: “Concordia Healthcare Corp. Announces Name Change to Concordia International …” published on June 28, 2016, Prnewswire.com published: “Concordia International Corp. Announces FDA Approval for New Photofrin® Laser” on June 30, 2016. More interesting news about Concordia International Corp (NASDAQ:CXRX) were released by: Prnewswire.com and their article: “Concordia International Corp. Issues Statement On Sale Of Company Stock” published on August 22, 2016 as well as Fool.ca‘s news article titled: “Concordia International Corp.: A Safe Buy?” with publication date: October 10, 2016.
December 19, 2016 Vivian Park
Stock Worth Mentioning: Will Concordia International Corp Go Down Anytime Soon?
The stock of Concordia International Corp (NASDAQ:CXRX) is a huge mover today! The stock increased 7.91% or $0.17 on December 19, hitting $2.32. About 2.55 million shares traded hands or 10.39% up from the average. Concordia International Corp (NASDAQ:CXRX) has declined 92.60% since May 16, 2016 and is downtrending. It has underperformed by 101.87% the S&P500.
The move comes after 7 months positive chart setup for the $109.69 million company. It was reported on Dec, 19 by Barchart.com. We have $2.41 PT which if reached, will make NASDAQ:CXRX worth $4.39M more.
Analysts await Concordia International Corp (NASDAQ:CXRX) to report earnings on March, 22. They expect $-0.03 EPS, down 102.78% or $1.11 from last year’s $1.08 per share. After $-0.33 actual EPS reported by Concordia International Corp for the previous quarter, Wall Street now forecasts -90.91% EPS growth.
Concordia International Corp (NASDAQ:CXRX) Ratings Coverage
Out of 9 analysts covering Concordia Healthcare Corp. (NASDAQ:CXRX), 5 rate it a “Buy”, 0 “Sell”, while 4 “Hold”. This means 56% are positive. Concordia Healthcare Corp. has been the topic of 18 analyst reports since August 11, 2015 according to StockzIntelligence Inc. The firm earned “Sector Outperform” rating on Friday, October 16 by Scotia Capital. The firm has “Sector Outperform” rating by Scotia Capital given on Tuesday, September 29. The company was initiated on Monday, November 30 by IBC. The rating was maintained by S&P Research on Friday, October 16 with “Buy”. RBC Capital Markets reinitiated it with “Outperform” rating and $86 target price in Thursday, October 1 report. On Monday, September 19 the stock rating was upgraded by Scotia Capital to “Sector Perform”. Goldman Sachs initiated Concordia International Corp (NASDAQ:CXRX) on Monday, June 6 with “Neutral” rating. The company was upgraded on Monday, October 19 by Mackie. Laurentian maintained the stock with “Buy” rating in Tuesday, March 29 report. The stock of Concordia International Corp (NASDAQ:CXRX) has “Hold” rating given on Thursday, August 4 by TD Securities.
According to Zacks Investment Research, “Concordia International Corp is a diverse pharmaceutical company which focused on legacy pharmaceutical products and orphan drugs. The company also markets orphan drugs through its Orphan Drug Division, currently consisting of Photofrin(R) for the treatment of certain rare forms of cancer, which is currently undergoing testing for potential new indications. Concordia International Corp, formerly known as Concordia Healthcare Corp, is headquartered in Oakville, Canada.”
More notable recent Concordia International Corp (NASDAQ:CXRX) news were published by: Reuters.com which released: “BRIEF-Concordia International Corp provides business update” on December 19, 2016, also Prnewswire.com with their article: “Concordia Healthcare Corp. Announces Name Change to Concordia International …” published on June 28, 2016, Prnewswire.com published: “Concordia International Corp. Announces FDA Approval for New Photofrin® Laser” on June 30, 2016. More interesting news about Concordia International Corp (NASDAQ:CXRX) were released by: Prnewswire.com and their article: “Concordia International Corp. Issues Statement On Sale Of Company Stock” published on August 22, 2016 as well as Fool.ca‘s news article titled: “Concordia International Corp.: A Safe Buy?” with publication date: October 10, 2016.
(0)
(0)
I'm in it to win it!
NASDAQ DIP and RIP
Here is the best word that describes what i do here.
Intuitive;
means having the ability to understand or know something without any direct evidence or reasoning process.
I was born with it, I'm truly blessed!
Alway's searching for winners'
NASDAQ DIP and RIP
Here is the best word that describes what i do here.
Intuitive;
means having the ability to understand or know something without any direct evidence or reasoning process.
I was born with it, I'm truly blessed!
Alway's searching for winners'